Rep. Lisa C. McClain Buys Healthpeak Properties, Inc. (NYSE:DOC) Stock

Key Points

• Rep. Lisa C. McClain purchased shares of Healthpeak Properties, Inc. (NYSE:DOC) valued between $1,001 and $15,000 on June 17th, reflecting her investment in the real estate sector.
• Healthpeak reported a quarterly EPS of $0.46, meeting analyst expectations, but experienced a 0.2% decline in revenue year-over-year.
• The company announced a dividend of $0.1017 per share, which will be paid on August 29th, representing a dividend yield of 705.0%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Healthpeak Properties, Inc. NYSE: DOC. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Healthpeak Properties stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $17.2260 on Thursday. The firm's 50 day moving average price is $17.62 and its 200-day moving average price is $18.42. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26. The firm has a market cap of $11.97 billion, a P/E ratio of 71.78, a P/E/G ratio of 2.20 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. During the same period in the prior year, the business posted $0.45 EPS. The business's revenue for the quarter was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be issued a $0.1017 dividend. This represents a dividend yield of 705.0%. The ex-dividend date is Monday, August 18th. Healthpeak Properties's dividend payout ratio is currently 508.33%.

Institutional Investors Weigh In On Healthpeak Properties

Large investors have recently modified their holdings of the company. TCTC Holdings LLC increased its position in shares of Healthpeak Properties by 124.3% in the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares during the last quarter. Brooklyn Investment Group increased its position in shares of Healthpeak Properties by 198.9% in the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 873 shares during the last quarter. Rexford Capital Inc. purchased a new stake in shares of Healthpeak Properties in the 2nd quarter valued at approximately $28,000. Future Financial Wealth Managment LLC purchased a new stake in shares of Healthpeak Properties in the 1st quarter valued at approximately $30,000. Finally, S.A. Mason LLC increased its position in shares of Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares during the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Scott M. Brinker acquired 1,490 shares of the company's stock in a transaction on Monday, August 4th. The shares were bought at an average cost of $16.83 per share, with a total value of $25,076.70. Following the transaction, the chief executive officer owned 211,906 shares in the company, valued at approximately $3,566,377.98. This trade represents a 0.71% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Tommy G. Thompson acquired 5,777 shares of the company's stock in a transaction on Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the transaction, the director owned 144,290 shares in the company, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 14,560 shares of company stock worth $249,898. Insiders own 0.23% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $18.00 price objective (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday. Robert W. Baird set a $21.00 price objective on shares of Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Scotiabank downgraded shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and cut their target price for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Evercore ISI cut their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Finally, Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Seven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, Healthpeak Properties has a consensus rating of "Moderate Buy" and an average target price of $22.09.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.